Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James D Hilger

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Vision|January 17, 2009
Surface interpolation and 3D relatabilityCarlo Fantoni, James D Hilger, Walter Gerbino, et al.
Vision Research|October 27, 2009
A unified model of illusory and occluded contour interpolationDonald J Kalar, Patrick Garrigan, Thomas D Wickens, et al.
Annals of Hematology|October 19, 2013
A phase 1/2 study of oral panobinostat combined with melphalan for patients with relapsed or refractory multiple myelomaJames R Berenson, James D Hilger, Ori Yellin, et al.
British Journal of Haematology|September 29, 2011
A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patientsJames R Berenson, Ori Yellin, Chien-Shing Chen, et al.
Blood|July 23, 2020
Zanubrutinib for the treatment of patients with Waldenström macroglobulinemia: 3 years of follow-upJudith Trotman, Stephen Opat, David Gottlieb, et al.
American Journal of Hematology|December 2, 2010
Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acidJames R Berenson, Ori Yellin, John Crowley, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Vision|January 17, 2009
Surface interpolation and 3D relatabilityCarlo Fantoni, James D Hilger, Walter Gerbino, et al.
Vision Research|October 27, 2009
A unified model of illusory and occluded contour interpolationDonald J Kalar, Patrick Garrigan, Thomas D Wickens, et al.
Annals of Hematology|October 19, 2013
A phase 1/2 study of oral panobinostat combined with melphalan for patients with relapsed or refractory multiple myelomaJames R Berenson, James D Hilger, Ori Yellin, et al.
British Journal of Haematology|September 29, 2011
A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patientsJames R Berenson, Ori Yellin, Chien-Shing Chen, et al.
Blood|July 23, 2020
Zanubrutinib for the treatment of patients with Waldenström macroglobulinemia: 3 years of follow-upJudith Trotman, Stephen Opat, David Gottlieb, et al.
American Journal of Hematology|December 2, 2010
Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acidJames R Berenson, Ori Yellin, John Crowley, et al.
Pageof 1